| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/21/2004 | EP1438283A1 Dicarboxylic acid derivatives, their preparation and therapeutic use |
| 07/21/2004 | EP1438281A2 Functionalized stilbene derivatives as improved vascular targeting agents |
| 07/21/2004 | EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 07/21/2004 | EP1438073A2 Polyoxyalkylenes conjugates as enzyme inhibitors |
| 07/21/2004 | EP1438071A1 Therapies for treating respiratory diseases |
| 07/21/2004 | EP1438070A1 Treating vascular disease by inhibiting toll-like receptor-4 |
| 07/21/2004 | EP1438069A1 Enzyme inhibitors for inactivating allergens |
| 07/21/2004 | EP1438067A1 Autologous growth factor cocktail composition, method of production and use |
| 07/21/2004 | EP1438061A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 07/21/2004 | EP1438055A1 D-tagatose as an anti-biofilm agent |
| 07/21/2004 | EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438049A2 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1438045A1 Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake |
| 07/21/2004 | EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents |
| 07/21/2004 | EP1438043A2 Method of reducing type 2 diabetes in high risk patients |
| 07/21/2004 | EP1438039A2 Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 07/21/2004 | EP1438035A2 Pharmaceutical compositions for the treatment of urinary disorders |
| 07/21/2004 | EP1438031A1 Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 07/21/2004 | EP1438022A1 Drug release system for controlled therapy |
| 07/21/2004 | EP1438015A2 Cosmetic and dermopharmaceutical compositions for skin prone to acne |
| 07/21/2004 | EP1437961A2 Methods of suppressing microglial activation |
| 07/21/2004 | EP1404351A4 Carbohydrate modifying agent and drinks containing the modifying agent |
| 07/21/2004 | EP1357977B1 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 07/21/2004 | EP1292608B1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 07/21/2004 | EP1268833B1 Modified nodavirus rna for gene delivery |
| 07/21/2004 | EP1254251A4 Neurosteroids as markers for alzheimer's disease |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1200110A4 In vivo induction for enhanced function of isolated hepatocytes |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP1143999B1 Lipoprotein complexes and compositions containing them |
| 07/21/2004 | EP1067941B1 Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate |
| 07/21/2004 | EP1047692B1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors |
| 07/21/2004 | EP0975604B1 Pyridazinones as inhibitors of cyclooxygenase-2 |
| 07/21/2004 | EP0958282B1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 07/21/2004 | EP0937040B1 N-substituted 2-cyanopyrrolidines |
| 07/21/2004 | EP0932402B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 07/21/2004 | EP0757685B1 Novel acyclic and cyclic amides as neurotransmitter release enhancers |
| 07/21/2004 | EP0643775B1 Quinone derivatives for enhancing cellular bioenergy |
| 07/21/2004 | CN1514833A Novel tyrosine kinase inhibitors |
| 07/21/2004 | CN1514831A Medicinal composition containing 1,3-thiazine derivative |
| 07/21/2004 | CN1514828A Pyrazole derivatives for treating HIV |
| 07/21/2004 | CN1514737A Method of treatment of vascular regeneration |
| 07/21/2004 | CN1514736A Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 07/21/2004 | CN1514735A Ophthalmic composition comprising hyaluronic acid |
| 07/21/2004 | CN1514729A Sustained-release analgesic compounds |
| 07/21/2004 | CN1514727A Favorable modulation of health-related quality of life and health-related quality-adjusted time-to progression of disease in patients with prostate cancer |
| 07/21/2004 | CN1514726A Pharmaceutical compositions |
| 07/21/2004 | CN1514725A Pharmaceutical composition comprising lipase inhibitor and sucrose fatty acid ester |
| 07/21/2004 | CN1513837A Clausend wanpi acidamine C5 hydroxy derivative and N substituted derivative, its preparation method and its medicinal composition and use |
| 07/21/2004 | CN1513546A Transfer factor preparation for venoclysis |
| 07/21/2004 | CN1513504A Composition of six drugs containing rehmanmine reaeparatae for antifatigue |
| 07/21/2004 | CN1513469A Regulatary factor T for cell growth, and its prepn. method |
| 07/21/2004 | CN1158290C Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/21/2004 | CN1158287C Benzothieno [3,2-c] pyridines as alpha 2-antagonists |
| 07/21/2004 | CN1158284C Porphyrins and their use |
| 07/21/2004 | CN1158283C 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 07/21/2004 | CN1158279C 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for production and utilization thereof and pharmaceutical preparations containing said compounds |
| 07/21/2004 | CN1158277C Farnesyl transferase inhibitors having piperidine structure and process for preparation thereof |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158269C 4-aminothiazole 2 group compound as inhibitors of cyclin-dependent kinases |
| 07/21/2004 | CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 07/21/2004 | CN1158258C Alpha 1 beta-adrenergic receptor antagonists |
| 07/21/2004 | CN1158256C Pyrrolidine derivatives-CCR-3 receptor antagonists |
| 07/21/2004 | CN1158070C Immediate release tablet |
| 07/20/2004 | US6765105 Compound and pharmaceutical composition of antiplasmid effect and the preparation thereof |
| 07/20/2004 | US6765095 2,3-disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| 07/20/2004 | US6765022 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765011 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 07/20/2004 | US6765010 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765005 Fab I inhibitors |
| 07/20/2004 | US6765004 Anticoagulants, antiischemic and hypotensive agents; cardiovascular disorders, congestive heart failure, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, strokes |
| 07/20/2004 | US6765003 3-Arylsulfonyl-2 (substituted methyl) propanoic acid derivatives as matrix metalloproteinase inhibitors |
| 07/20/2004 | US6764838 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/20/2004 | US6764826 Detcting modulators of c-reactive proteins; obtain c-reactive protein, incubate with modulator, monitor binding between reactive protein and modulator |
| 07/20/2004 | US6764687 Live attenuated bacteria for use in a vaccine |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | US6764679 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 07/20/2004 | US6764678 Local anesthetic methods and kits |
| 07/20/2004 | US6763607 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 07/20/2004 | CA2292388C Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 07/20/2004 | CA2286733C Reverse-turn mimetics and methods relating thereto |
| 07/20/2004 | CA2257136C Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/20/2004 | CA2216634C Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 07/20/2004 | CA2087957C Tissue bonding and sealing composition and method of using the same |
| 07/20/2004 | CA2085555C Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them |
| 07/20/2004 | CA2082420C Wound healing composition comprising purified igf-i or igf-ii and a purified tgf-.beta. |
| 07/15/2004 | WO2004058790A1 Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof |
| 07/15/2004 | WO2004058788A1 Lipid a analogues having glucose as the right sugar |
| 07/15/2004 | WO2004058772A1 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same |
| 07/15/2004 | WO2004058767A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 07/15/2004 | WO2004058745A1 Optically active dihydropyridine derivative |
| 07/15/2004 | WO2004058742A1 Benzocycloheptapyridine compounds |
| 07/15/2004 | WO2004058728A1 Novel ethylenediamine derivatives |
| 07/15/2004 | WO2004058706A1 Clausenamide c5 hydroxyl derivatives and n-substituted derivatives, processes for their preparation, its composition and use |